Navigation Links
Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections
Date:2/23/2009

BIRMINGHAM, Ala., Feb. 23 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals (Nasdaq: BCRX) today announced that the full data set from an exploratory Phase 2 study of peramivir in patients hospitalized for influenza was presented by the study's Principal Investigator, Dr. Michael G. Ison, Assistant Professor, Divisions of Infectious Diseases and Organ Transplantation at Northwestern University Feinberg School of Medicine, during the XI International Symposium on Respiratory Viral Infections taking place in Bangkok, Thailand, February 19 through February 22, 2009. This exploratory Phase 2 trial compared the efficacy and safety of five days of therapy with either 200 mg intravenous (i.v.) peramivir per day, 400 mg i.v. peramivir per day or 75 mg oral oseltamivir twice-a-day, in patients who required hospitalization related to influenza.

The primary objective of the study was to evaluate time to clinical stability, which is a composite endpoint comprised of normalization of temperature, oxygen saturation, respiratory rate, systolic blood pressure and heart rate. This type of endpoint has previously been used in pneumonia studies, but not in influenza. Secondary objectives of the study included evaluation of viral shedding, mortality, clinical relapse and time to resumption of usual activities. The primary efficacy population was defined as patients with confirmed influenza.

As reported in October 2008, there were no statistically significant differences in any of the efficacy endpoints between the three treatment arms, and peramivir was generally safe and well-tolerated at these dose levels. Evaluation of time to clinical stability, the primary endpoint, showed a median of 23.7 hours for peramivir 200 mg, 37.0 hours for peramivir 400 mg and 28.1 hours for oseltamivir (p=0.306). This exploratory endpoint was driven b
'/>"/>

SOURCE BioCryst Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA
2. Abbott and Enanta Initiate Phase 1 Clinical Trial on ABT-450 HCV Protease Inhibitor
3. Novavax Presents Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program at World Health Organization Conference
4. Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile
5. Groundbreaking Paper Publishes Long Term Results of a Successful Phase I Clinical Trial Using Autologous Neural Stem Cells to Treat Parkinsons Disease
6. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
7. Inspiration Biopharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of IB1001 for the Treatment of Hemophilia B
8. Phase 1 Trial of Quadramet in Combination with Velcade Shows Positive Results
9. Genaera Presents Preliminary Phase 1b Data for Trodusquemine (MSI-1436)
10. Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH)
11. Cytopia Concludes Phase I Oral Trial for Vascular-Disrupting Agent, CYT997
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... 27, 2015 Research and Markets ( ... "Intraoperative Imaging Market by Type (Intraoperative CT, Intraoperative MRI, ... to their offering. The global intraoperative imaging ... 3.5% from 2014 to 2019 It holds ... number of forces that favor this market. The need ...
(Date:3/31/2015)... , March 31, 2015 ... "Life Science and Chemical Instrumentation Market (Chromatography, Electrophoresis, DNA ... Flow Cytometer, Incubator, Fume Hood, Centrifuge) - Global ... Life Science and Chemical Instrumentation Market is expected ... of 6.9% from 2014 to 2019. ...
(Date:3/31/2015)... March 31, 2015  SCILEX Pharmaceuticals, Inc., a company ... on the treatment of pain, today announced that ITOCHU ... ), a member of ITOCHU Corporation ( Tokyo ... leading sogo shosha (general trading companies) in ... SCILEX.  ICF has worked closely with SCILEX as an ...
Breaking Medicine Technology:Global Intraoperative Imaging (Intraoperative CT, Intraoperative MRI, Intraoperative Ultrasound) Market 2015-2019 2Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 2Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 3Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 4Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 5SCILEX Pharmaceuticals Announces Strategic Investment By ITOCHU CHEMICAL FRONTIER Corporation 2
... May 1 The clinical impact of the first-ever,pro-healing stent, ... at next month,s 16th Annual Scientific Congress of,the Hong Kong ... Sheraton Hong Kong Hotel, the one-hour,session will include:, ... Tse, M.D., of the Hong Kong ...
... Diabetes Association and Richard and Susan Smith Family,Foundation ... ALEXANDRIA, Va., April 30 The American,Diabetes Association ... human type 2 diabetes genes in mice, and ... genetic causes of type 2 diabetes. The,projects will ...
Cached Medicine Technology:Clinical Impact of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) is Subject of Symposium at 16th Annual Scientific Congress of Hong Kong College of Cardiology 2Continued Funding to Help Advance 'Exciting Moment' in Diabetes Research 2
(Date:4/1/2015)... Enterprise Integration has appeared on ... distinguished list and report identifying the world’s top ... list is currently available on the MSPmentor. Additional ... MSPs in North America ,     The top ...     The top MSPs in Asia, Australia and ...
(Date:3/31/2015)... Bon Secours New York Health System ... Nursing Care Center family last week. The Sisters formerly ... Yonkers which is scheduled to close later this year. ... the Sisters of Charity of New York, the decision ... place their Sisters at Schervier Nursing Care Center followed ...
(Date:3/31/2015)... On November 24, 2014, Per Wickstrom had an opportunity ... problem of substance abuse and the solutions that are offered ... and recovery, gives a unique first-person perspective on addiction and ... the New York Giants, Taylor’s early career was almost cut ... he was able to straighten out long enough to make ...
(Date:3/31/2015)... 31, 2015 Over the last several ... technique have yielded better results and more efficient ... and perfected by a good hair transplant surgeon, has ... techniques of hair restoration have improved the efficiency of ... used to add precision and flexibility to the field ...
(Date:3/31/2015)... Dr. Parsa Mohebi, founder of Parsa Mohebi Hair Restoration has ... of using beard hair to fill in balding areas ... has now become an absolute option for giving patients the best ... believe that beard to scalp hair transplant can be a patients ... as dense as we would like it,” says Dr. Parsa Mohebi. ...
Breaking Medicine News(10 mins):Health News:Penton Technology Names Enterprise Integration to the MSPmentor 501 Global Edition 2Health News:Penton Technology Names Enterprise Integration to the MSPmentor 501 Global Edition 3Health News:Bon Secours New York Health System Welcomes Retired Sisters of Charity to the Family 2Health News:Lawrence Taylor & Per Wickstrom Discuss the Drug Rehabilitation & Recovery Process 2Health News:Beverly Hills Hair Transplant Surgeon Now Combines Advanced Robotic Hair Transplantation and Manual Techniques for Greatest Results 2Health News:Is Beard to Scalp Hair Transplant the Future? 2
... ... a symptom of cancer rather than a cause.,• Possible benefit of higher HDL and cancer ... ... Association for Cancer Research hosted a press briefing on this study on Tuesday, Nov. 3, ...
... half of those with lung disease symptoms remain undiagnosed, experts ... Americans are aware of chronic obstructive pulmonary disease (COPD), but ... be treated, according to national survey results released this week ... Month in November. , COPD affects 20 percent of U.S. ...
... , ... of the US Food and Drug Administration (FDA), will deliver the opening keynote address to ... (DIA) 46th Annual Meeting. , ... Horsham, PA (Vocus) November 4, 2009 -- Dr. Margaret Hamburg, Commissioner of the ...
... , ... BibsToGo.com launches a line of disposable, recyclable and customizable bibs to help keep both children ... Video Solutions of Rye, NY. , ... ,Dix Hills, NY (PRWEB) November 4, 2009 -- Andre Muller is a ...
... In order to help millions of Americans ... conditions, depression and obesity, the Neutraceutical Company, LLC ... the ability to address both issues safely and ... brand, has clinically established a remarkable success in ...
... Jude Children,s Research Hospital launched the sixth annual Thanks ... retail and corporate partners that ask consumers to "Give thanks ... those who are not." The announcement was made today by ... , For the first time, GRAMMY® Award-nominated singer and ...
Cached Medicine News:Health News:Cholesterol and Cancer: Answers and Some New Questions 2Health News:Cholesterol and Cancer: Answers and Some New Questions 3Health News:Cholesterol and Cancer: Answers and Some New Questions 4Health News:Cholesterol and Cancer: Answers and Some New Questions 5Health News:Americans Gaining Awareness of COPD: Survey 2Health News:FDA Commissioner Margaret Hamburg to Deliver Keynote Address at DIA 46th Annual Meeting, June 13-17, 2010 in Washington, DC , 2Health News:FDA Commissioner Margaret Hamburg to Deliver Keynote Address at DIA 46th Annual Meeting, June 13-17, 2010 in Washington, DC , 3Health News:BibsToGo.com Answers: How Can a Traditional Baby Product Help Corporate America Look Better? 2Health News:New Product Launch - SAFFRENE Delivers Impressive Mood Elevation and Weight-loss Benefits 2Health News:Stars of Film, Television, Sports and Music Join Marlo Thomas to Kick Off the 6th Annual Thanks and Giving(R) Campaign to Support St. Jude Children's Research Hospital(R) 2Health News:Stars of Film, Television, Sports and Music Join Marlo Thomas to Kick Off the 6th Annual Thanks and Giving(R) Campaign to Support St. Jude Children's Research Hospital(R) 3Health News:Stars of Film, Television, Sports and Music Join Marlo Thomas to Kick Off the 6th Annual Thanks and Giving(R) Campaign to Support St. Jude Children's Research Hospital(R) 4Health News:Stars of Film, Television, Sports and Music Join Marlo Thomas to Kick Off the 6th Annual Thanks and Giving(R) Campaign to Support St. Jude Children's Research Hospital(R) 5
... Rapid exchange thrombectomy never ... with tortuous anatomy in mind, ... cut shaft, soft tip and ... trackability, and pushability. Glide in ...
... Radiometer's 1st automatic is an automated ... samplers and IT to reduce the steps ... operator safety, and minimize errors. The 1st ... arterial sampler, FLEXLINK software, and FLEXQ automatic ...
... three software components that comprise the ... software components comprise the SmartPill GI ... SmartPill Data Receiver software and SmartPill ... integrated and indispensable parts of the ...
... is the new second-generation application software for ... ,This software release includes a range ... efficiency and userfriendliness. Included are automatic tools ... Blood Indicator (SBI) which highlights images that ...
Medicine Products: